When was CareDx founded?

CareDx was founded in 1998 and raised its 1st funding round 6 years after it was founded.

Where is CareDx located?

CareDx is headquartered in Brisbane, United States. It is registered at 1 Tower Place South San Francisco, California 94080.

How many employees does CareDx have?

As of Sep 30, 2026, the latest employee count at CareDx is 856.

Is CareDx a funded company?

CareDx is a funded company, having raised a total of $138M across 18 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Apr 2004.

When was the latest funding round of CareDx?

CareDx's latest funding was a $***** Conventional Debt round on Mar 01, 2018, with participation from 1 investor.

What is the annual revenue of CareDx?

Annual revenue of CareDx is between $100M and $500M as on Dec 31, 2025

Where does CareDx rank among its competitors?

CareDx ranks 1st amongst 24 active competitors, of which 7 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was CytoDyn, which secured $17.5M in Mar, 2026.

Who are the top competitors of CareDx?

CareDx's top competitors include Tonix Pharma, Quell and Kedrion. Among them, CytoDyn secured the most recent funding round in March, 2026.

CareDx - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of medical solutions for transplant patients. It has developed precision medicine solutions that offer products, testing services, and digital healthcare solutions along with the pre-and post-transplant patient journey. It provides AlloSure products for a kidney transplant. It is a non-invasive donor-derived cell-free DNA test for identifying kidney injury. It can determine active rejection, enabling better management of your kidney transplant patients. Other products include heart transplants, lab products, remotrac, and others.

Website: www.caredx.com/
Social
Email ID: *****@caredx.com
Phone Number: +1 **********
Registered Address: 1 Tower Place South San Francisco, California 94080

Key Metrics

Founded Year

1998

Location

Brisbane, United States

Stage

Public

Total Funding

$138M in 18 rounds

Latest Funding Round

Conventional Debt, Mar 01, 2018, $*****

Investors

Intel & 25 more

Ranked

1^st among 24 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2025

Employee Count

856 as on Sep 30, 2026

Investment & Acquisitions

Naveris & 12 more

Similar Companies

Tonix Pharma & 23 more

Exit Details

Public

View CareDx's full profile

CareDx is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Caredx, Inc. CIN: 1217234 , United States, Active	Dec 20, 1998	$100M - $500M (As on Dec 31, 2025)	-	-
CAREDX, INC CIN: 94-3316839 , United States, Active	Dec 31, 1997	-	645 (As on Dec 31, 2021)	-

CareDx got listed on Jul 17, 2014.

Click here to take a look at CareDx's IPO in detail

CareDx has raised a total funding of $138M over 18 rounds. Its first funding round was on Apr 2004. Its latest funding round was a Conventional Debt round on Mar 01, 2018 for $*****. 1 investor participated in its latest round. CareDx has 26 institutional investors.

Here is the list of recent funding rounds of CareDx:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 01, 2018	3892735	Conventional Debt	5431180	9843347	8459681	2249149
Mar 17, 2017	9642518	Post IPO	9286519	7461810	8279364	1725794
Jul 08, 2016	3685842	Post IPO	7418968	3755427	8333341	1250929

Access funding benchmarks and valuations. Sign up today!

View details of CareDx's funding rounds and investors

The founders of CareDx is Jay Wohlgemuth Md. Reginald Seeto is the CEO of CareDx.

Here are the details of CareDx's key team members:

Jay Wohlgemuth Md: Co-founder, CMO of CareDx.

View details of CareDx's Founder profiles and Board Members

CareDx's employee count trend

CareDx has 856 employees as of Sep 26. Here is CareDx's employee count trend over the years:

Uncover CareDx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CareDx include Tonix Pharma, Quell and Kedrion. Here is the list of Top 10 competitors of CareDx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CareDx 1998, Brisbane (United States), Public	Developer of medical solutions for transplant patients	$138M	Intel, Integral Capital Partners & 24 others	73/100
2nd	Tonix Pharma 2007, New York City (United States), Public	Developer of next-generation medicines for CNS and immunological disorders	$4.45M	Westwicke, Technology Partners & 2 others	66/100
3rd	Quell 2019, London (United Kingdom), Series B	Developer of engineered regulatory T cell therapies for immune diseases	$344M	Syncona, Fidelity Investments & 17 others	65/100
4th	Kedrion 2001, Barga (Italy), Acquired	Developer of plasma-derived products for hemophilia and immune system deficiencies	$189M	CDP Equity, Ampersand Capital & 4 others	60/100
5th	Eledon 2004, Irvine (United States), Public	Provider of therapeutics solution for organ or cellular transplantation in autoimmune and neurodegenerative disease	$1.89M	BVF Partners, Ridgeback Capital Management ... & 4 others	57/100
6th	CytoDyn 2002, Vancouver (United States), Public	Developer of humanized monoclonal antibodies for the treatment and prevention of HIV infection	-	4-Good Ventures, Centrecourt Asset Management ... & 1 others	52/100
7th	OSE Immunotherapeutics 1986, Nantes (France), Public	Developer of immunotherapies for immuno-oncology and autoimmune diseases	-	Inserm Transfert Initiative, Bpifrance	52/100
8th	ITBMed 2016, Stockholm (Sweden), Series A	Developer of monoclonal antibodies to prevent transplant rejections	$87M	3E Bioventures Capital, Yonjin Capital & 2 others	51/100
9th	Cellistic 2022, Charleroi (Belgium), Unfunded	Developer of iPSC-focused cell therapies to treat multiple diseases	-	-	46/100
10th	Garuda 2021, Natick (United States), Series B	Developer of stem cell-based therapies to treat multiple diseases	$182M	Aisling Capital, Northpond Ventures & 9 others	43/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on CareDx's competitors? Click here to see the top ones

CareDx has made 3 investments in companies including Miromatrix and Likvor. CareDx has also acquired 10 companies including Naveris and MediGO.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 28, 2026	Acquisition	Naveris	2017	Waltham (United States)
Jul 25, 2023	Acquisition	MediGO	2020	Baltimore (United States)
Nov 10, 2021	Acquisition	MedActionPlan	2001	Peapack (United States)